Formulation and evaluation of PLGA nanoparticulate-based microneedle system for potential treatment of neurological diseases
B Li, G Lu, W Liu, L Liao, J Ban, Z Lu - International Journal of …, 2023 - Taylor & Francis
Introduction The tight structure of the blood–brain barrier severely limits the level of drug
therapy for central nervous system disorders. In this study, a novel composite delivery …
therapy for central nervous system disorders. In this study, a novel composite delivery …
[HTML][HTML] Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases
B Li, G Lu, W Liu, L Liao, J Ban, Z Lu - International Journal of …, 2023 - ncbi.nlm.nih.gov
Methods Nanoparticle solutions containing paroxetine and rhodamine-B were prepared
using PLGA as a carrier by the emulsification-solvent volatilization method. Then, they were …
using PLGA as a carrier by the emulsification-solvent volatilization method. Then, they were …
Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases.
B Li, G Lu, W Liu, L Liao, J Ban, Z Lu - International Journal of …, 2023 - go.gale.com
Introduction: The tight structure of the blood-brain barrier severely limits the level of drug
therapy for central nervous system disorders. In this study, a novel composite delivery …
therapy for central nervous system disorders. In this study, a novel composite delivery …
Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases
B Li, G Lu, W Liu, L Liao, J Ban… - International journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction The tight structure of the blood-brain barrier severely limits the level of drug
therapy for central nervous system disorders. In this study, a novel composite delivery …
therapy for central nervous system disorders. In this study, a novel composite delivery …
Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases
B Li, G Lu, W Liu, L Liao, J Ban, Z Lu - International Journal of …, 2023 - dovepress.com
Methods: Nanoparticle solutions containing paroxetine and rhodamine-B were prepared
using PLGA as a carrier by the emulsification-solvent volatilization method. Then, they were …
using PLGA as a carrier by the emulsification-solvent volatilization method. Then, they were …
Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases.
B Li, G Lu, W Liu, L Liao, J Ban, Z Lu - International Journal of …, 2023 - europepmc.org
Methods Nanoparticle solutions containing paroxetine and rhodamine-B were prepared
using PLGA as a carrier by the emulsification-solvent volatilization method. Then, they were …
using PLGA as a carrier by the emulsification-solvent volatilization method. Then, they were …
[引用][C] Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases
B Li, G Lu, W Liu, L Liao, J Ban, Z Lu - International Journal of …, 2023 - europepmc.org
Results: The mean particle size of Rh-NPs was 96.25±2.26 nm; zeta potential of 15.89±1.97
mV; PDI of 0.120±0.079. Rh-NPs-DMNs had a high needle content of 96.11±1.27% and a tip …
mV; PDI of 0.120±0.079. Rh-NPs-DMNs had a high needle content of 96.11±1.27% and a tip …